ExodusPoint Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
ExodusPoint Capital Management's CCCC Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of C4 Therapeutics (CCCC) in Q3 2026, closing a stake of 580,195 shares — an estimated $2.71M sold.
ExodusPoint Capital Management first reported a position in CCCC in Q2 2022 and held it in 6 quarters. The position peaked at $2.71M in Q2 2026. 152 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- ExodusPoint Capital Management reported no remaining C4 Therapeutics position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 580,195 C4 Therapeutics shares in Q3 2026, an estimated $2.71M.
- ExodusPoint Capital Management first reported a position in C4 Therapeutics in Q2 2022 and held it in 6 quarters.
- ExodusPoint Capital Management's C4 Therapeutics position peaked at $2.71M in Q2 2026.
- 152 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.